[Interview Series] Interviews on the NCD Alliance Japan website – Ms. Yukiko Nishimura “Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases” (June 15, 2020)
date : 6/16/2020
![[Interview Series] Interviews on the NCD Alliance Japan website – Ms. Yukiko Nishimura “Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases” (June 15, 2020)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-04_en.jpg)
The mission of NCD Alliance Japan* is to achieve the creation of a system for NCD policy that is centered on the involvement of people receiving healthcare and other parties most affected by NCDs. To achieve this, it educates and supports leaders from among those most affected by NCDs so they can actively participate in policy creation, such as by serving on national committees and councils.
Please access the links below for the interview:
■ Ms. Yukiko Nishimura NEW
President, Advocacy Service for Rare and Intractable Diseases (NPO ASrid)
“Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases”
■ Mr. Hiroki Takeda
Chief Knowledge Officer, PPeCC (Power to the People with Chronic Conditions)
Executive Director, Japan Chronic Disease Self-Management Association
“Supporting the Activities of People Living with NCDs to Build an NCD-Friendly Society”
■ Mr.Shinsuke Amano
Chair, The Japan Federation of Cancer Patient Groups
CEO, Group Nexus Japan
“Collaborating across NCDs to achieve “societies in which even people affected by cancer can live with peace of mind””
■ Mr. Takeshi Shukunobe
President and CEO, PPeCC
President and CEO, Patienthood
“Creating a better healthcare environment through a collaborative platform involving people with NCDs and other people most affected”
*NCD Alliance Japan is a collaborative platform for civil society organizations in the NCD community, steered by the Health and Global Policy Institute, aiming to further promote comprehensive, cross-cutting NCD policies.
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Announcement] HGPI Endorsed “Civil Society’s Expectations for the Continuation and Development of Japan’s Global Health Initiatives” (March 17, 2025)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)